Withdrawn
NA
INTERVENTIONAL
NCT01582685
Exercise in Breast Cancer Survivors
View on ClinicalTrials.gov
Updated Dec 15, 2025
Brief Summary
The investigators hypothesize that exercise in postmenopausal breast cancer survivors will result in an increase in the plasma concentrations of angiostatic factors and a decrease in the plasma concentrations of angiogenic factors. Exercise is expected to result in a circulating angiostatic phenotype that inhibits adipose tissue mass, growth of breast cancer tumor, growth of microscopic residual disease after breast cancer resection, decreases rates of local-regional recurrence, decreases rates of distant recurrence, and increases survival.
Interventions
Name:
Exercise
Type:
BEHAVIORAL
Description:
The participant will exercise for 16 weeks under supervision. The exercise regimen is increased slowly over 16 weeks.
Primary Outcomes
Measure:
Number of participants that complete the study as a measure of feasibility of an exercise intervention in obese breast cancer survivors.
TimeFrame:
12 months
Description:
Number of participants that enroll in the study and actually complete the study
Trial Information
NCT ID
NCT01582685
Status
Withdrawn
Study Type
INTERVENTIONAL
Phases
NA
Sponsor
University of Mississippi Medical Center
Last Updated
December 15, 2025